Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | MEN1 | O00255 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | G6PC1 | P35575 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12422791 | 0.83 | G6PC1 (0.43) | KMT2AMEN1ALDH1A1G6PC1TSHR | |
| SCHEMBL12422802 | 0.79 | CYP2C19 (0.44) | KMT2AMEN1CNR2G6PC1CYP2C19 | |
| SCHEMBL12422886 | 0.77 | ACHE (0.54) | KMT2AMEN1ALDH1A1G6PC1TSHR | |
| SCHEMBL12422835 | 0.75 | CYP2C19 (0.49) | KMT2AMEN1ALDH1A1CYP2C19TSHR | |
| SCHEMBL12422811 | 0.75 | L3MBTL1 (0.46) | KMT2AMEN1ALDH1A1 | |
| SCHEMBL12422807 | 0.75 | ACHE (0.51) | KMT2AMEN1ALDH1A1G6PC1CYP2C19 | |
| SCHEMBL12422843 | 0.72 | MAPT (0.46) | KMT2AMEN1G6PC1MAPT | |
| SCHEMBL12422818 | 0.70 | PDPK1 (0.44) | CYP2C19SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL12422834 | 0.70 | G6PC1 (0.39) | KMT2AMEN1ALDH1A1G6PC1TSHR | |
| SCHEMBL28005578 | 0.70 | AOC3 (0.41) | ALDH1A1CYP2C19MAPTADRA2BSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7977020-B2 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-7977020-B2 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2011-07-12 | — | — | US | disclosed |
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SHARP KABUSHIKI KAISHA (JP) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080286671-A1 | Electrophotographic photoreceptor containing enamine compound, image formation apparatus provided with the same, enamine compound and method for producing the same | SLC1A2, SLC1A1, SLC18A1 | KMT2A 1002/4885MEN1 1117/4885ALDH1A1 869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.